Cardiotoxicity of antiemetic drugs in oncology: An overview of the current state of the art
Barni S, Petrelli F, Cabiddu M
Crit Rev Oncol Hematol. 2016 Jun;102:125-34
CARDIONCOLOGY.ORG ABSTRACT:
This study examines the cardio safety profile of antiemetic drugs, specifically 5HT3-RA drugs used for prevention of chemotherapy-induced nausea and vomiting in the oncology setting. General overview and recommendation about their use in medical oncology is provided in this article.
© All Rights Reserved
image source: https://www.youtube.com/watch?v=zD_CWMlrb5s